Cardiologists need to join the sleep community in completing clinical trials evaluating the treatment of obstructive sleep apnea (OSA) among patients at risk for developing cardiovascular disease (CVD), as well as patients with symptomatic CVD. The Journal of the American College of Cardiology published a list of key points in response to a review of the cardiovascular consequences of OSA, including mechanisms linking OSA and CVD and various treatment strategies for OSA. Read more >>>